Isoniazid-induced inhibition of GABAergic transmission enhances neurosteroid content in the rat brain

被引:39
作者
Barbaccia, ML
Roscetti, G
Trabucchi, M
Purdy, RH
Mostallino, MC
Perra, C
Concas, A
Biggio, G
机构
[1] UNIV CALIF SAN DIEGO,DEPT PSYCHIAT,SAN DIEGO,CA 92161
[2] UNIV CAGLIARI,DEPT EXPT BIOL,I-09123 CAGLIARI,ITALY
关键词
isoniazid; stress; GABA; neurosteroids; brain; plasma; rat;
D O I
10.1016/S0028-3908(96)00067-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Isoniazid (375 mg/kg, s.c.), a drug that decreases GABA(A) receptor-mediated transmission, elicited a time-dependent increase of neuroactive steroid (pregnenolone, progesterone and allotetrahydro-deoxycorticosterone) concentrations in rat brain and plasma. This treatment also time-dependently increased the plasma concentration of corticosterone. Brain and plasma neuroactive steroid levels peaked between 40 and 120 min after isoniazid administration, respectively, and returned to control values by 5 hr. Acute foot shock stress mimicked the effect of isoniazid by increasing in a time-dependent manner the same neuroactive steroids both in brain and plasma. Abecarnil (0.3 mg/kg, i.p.), a beta-carboline derivative with anxiolytic properties, antagonized the effect of both isoniazid and foot shock on brain and plasma neuroactive steroids and on plasma corticosterone level. These data indicate that an inhibition of central GABAergic transmission enhances the concentrations of THDOC and its precursors pregnenolone and progesterone in the rat brain and plasma as well as the plasma levels of corticosterone. This finding suggests that GABA exerts a tonic inhibitory action on the mechanisms involved in the regulation of the synthesis and release of these neuroactive steroids in the central nervous system and plasma. Copyright (C) 1996 Elsevier Science Ltd.
引用
收藏
页码:1299 / 1305
页数:7
相关论文
共 48 条
[1]   CYCLIC AMP-DEPENDENT INCREASE OF STEROIDOGENESIS IN BRAIN CORTICAL MINCES [J].
BARBACCIA, ML ;
ROSCETTI, G ;
TRABUCCHI, M ;
AMBROSIO, C ;
MASSOTTI, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 219 (03) :485-486
[2]   NEUROSTEROIDS IN THE BRAIN OF HANDLING-HABITUATED AND NAIVE RATS - EFFECT OF CO2 INHALATION [J].
BARBACCIA, ML ;
ROSCETTI, G ;
TRABUCCHI, M ;
CUCCHEDDU, T ;
CONCAS, A ;
BIGGIO, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 261 (03) :317-320
[3]   Stress-induced increase in brain neuroactive steroids: Antagonism by abecarnil [J].
Barbaccia, ML ;
Concas, A ;
Roscetti, G ;
Bolacchi, F ;
Mostallino, MC ;
Purdy, RH ;
Biggio, G .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 54 (01) :205-210
[4]   Time-dependent changes in rat brain neuroactive steroid concentrations and GABA(A) receptor function after acute stress [J].
Barbaccia, ML ;
Roscetti, G ;
Trabucchi, M ;
Mostallino, MC ;
Concas, A ;
Purdy, RH ;
Biggio, G .
NEUROENDOCRINOLOGY, 1996, 63 (02) :166-172
[5]   ANTICONVULSANT PROFILE OF THE PROGESTERONE METABOLITE 5-ALPHA-PREGNAN-3-ALPHA-OL-20-ONE [J].
BELELLI, D ;
BOLGER, MB ;
GEE, KW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 166 (02) :325-329
[6]   STRESS AND BETA-CARBOLINES DECREASE THE DENSITY OF LOW AFFINITY GABA BINDING-SITES - AN EFFECT REVERSED BY DIAZEPAM [J].
BIGGIO, G ;
CONCAS, A ;
SERRA, M ;
SALIS, M ;
CORDA, MG ;
NURCHI, V ;
CRISPONI, C ;
GESSA, GL .
BRAIN RESEARCH, 1984, 305 (01) :13-18
[7]   MECHANISMS BY WHICH DIAZEPAM, MUSCIMOL, AND OTHER DRUGS CHANGE CONTENT OF CGMP IN CEREBELLAR CORTEX [J].
BIGGIO, G ;
BRODIE, BB ;
COSTA, E ;
GUIDOTTI, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (08) :3592-3596
[8]   GABAERGIC AND DOPAMINERGIC TRANSMISSION IN THE RAT CEREBRAL-CORTEX - EFFECT OF STRESS, ANXIOLYTIC AND ANXIOGENIC DRUGS [J].
BIGGIO, G ;
CONCAS, A ;
CORDA, MG ;
GIORGI, O ;
SANNA, E ;
SERRA, M .
PHARMACOLOGY & THERAPEUTICS, 1990, 48 (02) :121-142
[9]   ANXIOLYTIC EFFECTS OF 3A-HYDROXY-5A[BETA]-PREGNAN-20-ONE - ENDOGENOUS METABOLITES OF PROGESTERONE THAT ARE ACTIVE AT THE GABA-A RECEPTOR [J].
BITRAN, D ;
HILVERS, RJ ;
KELLOGG, CK .
BRAIN RESEARCH, 1991, 561 (01) :157-161
[10]   BENZODIAZEPINE RECEPTOR LIGANDS WITH POSITIVE AND NEGATIVE EFFICACY [J].
BRAESTRUP, C ;
NIELSEN, M ;
HONORE, T ;
JENSEN, LH ;
PETERSEN, EN .
NEUROPHARMACOLOGY, 1983, 22 (12B) :1451-1457